Patent details

EP1381367 Title: ARIPIPRAZOLE ORAL SOLUTION

Basic Information

Publication number:
EP1381367
PCT Application Number:
PCT/US/2002/013048
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP027239649
PCT Publication Number:
WO/2002/085366
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
ARIPIPRAZOLE ORAL SOLUTION
French Title of Invention:
SOLUTION ORALE D'ARIPIPRAZOLE
German Title of Invention:
ORALE ARIPIPRAZOL-LÖSUNG
SPC Number:

Dates

Filing date:
24/04/2002
Grant date:
21/12/2011
EP Publication Date:
21/12/2011
PCT Publication Date:
31/10/2002
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
21/01/2004
EP B1 Publication Date:
21/12/2011
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
24/04/2019
Expiration date:
24/04/2022
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
11/06/2014
 
 

Name:
OTSUKA PHARMACEUTICAL CO., LTD.
Address:
KANDA-TSUKASAMACHI, CHIYODA-KU 2-9, 101-8535 TOKYO, Japan (JP)

History of Owners

From:
24/04/2002
To:
10/06/2014

Name:
Bristol-Myers Squibb Company
Address:
Lawrenceville-Princeton Road P.O. Box 4000, Princeton NJ 08543-4000, United States (US)

Agent

Name:
MARKS & CLERK LLP
From:
29/02/2012
Address:
BP 1775, 1017, LUXEMBOURG, Luxembourg (LU)
To:

Inventor

1

Name:
CHOU Joyce
Address:
United States (US)

2

Name:
PARAB Prakash
Address:
United States (US)

Priority

Priority Number:
286718 P
Priority Date:
25/04/2001
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 31/497;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
27/04/2018
Last Annual Fee Paid Number:
17
Last Annual Fee Paid Amount:
246 Euro
Payer:
Computer Packages INC
Filing date Document type Number of pages
12/08/2022 Request For Change 1
02/09/2022 Outgoing Correspondence 56